Analysis of plasma-based BRAF and NRAS mutation detection in patients with stage III and IV melanoma. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback